4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Zevra Therapeutics, Inc. (ZVRA) operates in the Biotechnology industry and is headquartered in Boston, United States with about 61 employees. Its market capitalization is roughly $824 million. In the fiscal year ended 2025-12-31, ZVRA reported $106M in revenue and $83M in net income.
Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform.
Interactive charts & full statements → Open the ZVRA valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $106M | $24M | $28M | $10M | — |
| Gross Profit | $90M | $16M | $25M | $10M | — |
| Operating Income (EBIT) | ($4M) | ($87M) | ($50M) | ($25M) | — |
| Net Income | $83M | ($106M) | ($46M) | ($27M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $36M | $34M | $26M | $26M | $20M |
| Gross Profit | $34M | $33M | $25M | $14M | $19M |
| Operating Income (EBIT) | $9M | $9M | $4M | ($12M) | ($5M) |
| Net Income | $38M | $12M | ($0M) | $75M | ($3M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $285M | $178M | $172M | $115M | — |
| Total Liabilities | $130M | $138M | $110M | $40M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ZVRA viewer.
About TickerBase · Data methodology & sources